<DOC>
	<DOC>NCT03045367</DOC>
	<brief_summary>This study evaluates the safety and efficacy simultaneous, trans-conjunctival, 25-Gauge vitrectomy and phacoemulsification with intraocular lens implant in patients with metamorphopsia and visual impairment due to idiopathic epiretinal membrane and cataract. All 30 patients recruited underwent complete ocular examination, visual acuity measurement with ETDRS, metamorphopsia assessment with M-Charts and Metamorphometry® and foveal thickness evaluation by sd-OCT preoperatively, at 30, 90, 180 days postoperatively.</brief_summary>
	<brief_title>Mid-term Evaluation of Metamorphopsia in Epiretinal Membrane Surgery</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Epiretinal Membrane</mesh_term>
	<mesh_term>Vision Disorders</mesh_term>
	<criteria>age &gt; 55 years visual acuity ≤ 20/40 idiopathic epiretinal membrane cataract Amsler test positive for metamorphopsia. previous ocular interventions other ocular diseases.</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Metamorphopsia</keyword>
	<keyword>Epiretinal membrane</keyword>
	<keyword>Vitrectomy</keyword>
</DOC>